CYCLOPHOSPHAMIDE FOR , USP for Haematological malignancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 7 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE FOR , USP was used for Haematological malignancy.

Most Reported Side Effects for CYCLOPHOSPHAMIDE FOR , USP

Side Effect	Reports	%	Deaths	Hosp.
Death	73	20.1%	73	1
Neoplasm progression	62	17.1%	62	0
Disease progression	39	10.7%	6	0
Neutropenia	32	8.8%	21	0
Thrombocytopenia	23	6.3%	22	0
Exposure during pregnancy	21	5.8%	0	0
Acute graft versus host disease	20	5.5%	0	0
Leukaemia recurrent	18	5.0%	18	0
Disease recurrence	16	4.4%	13	0
No adverse event	15	4.1%	0	0
Liver function test abnormal	7	1.9%	0	0
Precursor t-lymphoblastic lymphoma/leukaemia recurrent	6	1.7%	0	0
Bacteraemia	5	1.4%	0	0
Chronic graft versus host disease	5	1.4%	0	0
Dehydration	5	1.4%	0	4